[In the Media] “No Time to Lose in Tackling Dementia: How Should Medicine and Big Pharma Address This Global Challenge?” (Nikkei-Gooday)
date : 11/27/2015
This article featured a conversation between Kiyoshi Kurokawa, Member of the G7 World Dementia Council, and Mr. Joji Nakayama, Representative Director, President & CEO of Daiichi Sankyo Co., Ltd.
For full article:
“No Time to Lose in Tackling Dementia: How Should Medicine and Big Pharma Address This Global Challenge?” (Nikkei-Gooday)
*Available only in Japanese.
Dementia is increasingly becoming an issue around the world. OECD and HGPI co-organized a Private Sector Side Meeting alongside the G7 Global Dementia Legacy Event organized by the Japanese Government in November 2014 in Tokyo.
For more information;
Taking Action on Dementia: Opportunities for Social Investment- A G7 Global Dementia Legacy Event Private Sector Side Meeting
HGPI followed up by submitting a policy recommendation. Later the National Strategy of Dementia was revised and released as what is called the New Orange plan in January 2015 moving dementia policy forward.
For full article:
“No Time to Lose in Tackling Dementia: How Should Medicine and Big Pharma Address This Global Challenge?” (Nikkei-Gooday)
*Available only in Japanese.
Dementia is increasingly becoming an issue around the world. OECD and HGPI co-organized a Private Sector Side Meeting alongside the G7 Global Dementia Legacy Event organized by the Japanese Government in November 2014 in Tokyo.
For more information;
Taking Action on Dementia: Opportunities for Social Investment- A G7 Global Dementia Legacy Event Private Sector Side Meeting
HGPI followed up by submitting a policy recommendation. Later the National Strategy of Dementia was revised and released as what is called the New Orange plan in January 2015 moving dementia policy forward.
Top Research & Recommendations Posts
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
Featured Posts
-
2026-02-13
[Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
-
2026-03-03
[Registration Open] Online Seminar “Implementing Chronic Kidney Disease (CKD) Measures into Society: Towards a Data-Driven Health System” (April 21, 2026)
-
2026-03-23
[Registration Open] (Hybrid Format) Kick-off Symposium: Rethinking Social Investment in “Brain Health” (April 6, 2026)
-
2026-03-23
[Registration Open] Application for the Health Policy Academy the 15th Session (Session Starts July 2026)
-
2026-04-01
[Registration Open] (Webinar) The 143rd HGPI Seminar “20 Years Since the Enactment of the Cancer Control Act: Reflecting on the Past and Envisioning the Next 20 Years” (April 28, 2026)



